Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2023 Jul 26;16:641–642. doi: 10.2147/OTT.S432297

Upregulated miR-27a-3p Indicates a Poor Prognosis in Pancreatic Carcinoma Patients and Promotes the Angiogenesis and Migration by Epigenetic Silencing of GATA6 and Activating VEGFA/VEGFR2 Signaling Pathway [Retraction]

PMCID: PMC10387267  PMID: 37525844

Rao X, Wan L, Jie Z, Zhu X, Yin J, Cao H. Onco Targets Ther. 2019;12:11241–11254.

We, the Editors and Publisher of OncoTargets and Therapy, have retracted the published article.

Since publication, concerns have been raised about the integrity of the data in the article. When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As verifying the validity of the published work is core to the integrity of the scholarly record, we are therefore retracting the article and the authors were notified of this.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.


Articles from OncoTargets and Therapy are provided here courtesy of Dove Press

RESOURCES